Cavitary pulmonary tuberculosis during treatment with guselkumab

J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e488-e490. doi: 10.1111/jdv.17992. Epub 2022 Feb 17.

Authors

A Cerejeira¹, G Canelas², J Vide¹, R Duro², F Azevedo¹, S Magina^{1

3}

Affiliations

¹ Department of Dermatology and Venereology, Centro Hospitalar Universitário São João, EPE Porto, Porto, Portugal.
² Department of Infectious Diseases, Centro Hospitalar Universitário São João, EPE Porto, Porto, Portugal.
³ Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

PMID: 35138650
DOI: 10.1111/jdv.17992

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Tuberculosis, Pulmonary* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
guselkumab